Prosensa Files F-3 SEC Mixed Shelf Registration For Up To $150 Million

Leiden, The Netherlands, July 7, 2014 (GLOBE NEWSWIRE) — Prosensa Holding N.V. (NASDAQ: RNA) the Dutch bio­phar­ma­ceu­ti­cal com­pa­ny focus­ing on rare dis­eases with a high unmet med­ical need, today con­firmed that on July 3 (one year fol­low­ing the clos­ing of its IPO), it filed a shelf reg­is­tra­tion state­ment with the US Securities and Exchange Commission. The fil­ing of the reg­is­tra­tion state­ment is not an offer­ing to sell secu­ri­ties and is intend­ed to enable Prosensa the flex­i­bil­i­ty to raise up to $150 mil­lion in one or more offer­ings while the shelf reg­is­tra­tion state­ment is effec­tive, if the com­pa­ny choos­es to do so. The spe­cif­ic terms of any secu­ri­ties that the Company may offer, if it choos­es to do so, will be deter­mined at the time of such offer­ing and will be described in a sep­a­rate­ly filed prospec­tus sup­ple­ment at the time of such offer­ing. The shelf reg­is­tra­tion state­ment also includes the shares of Prosensa’s three largest share­hold­ers. There are no imme­di­ate plans to offer or sell secu­ri­ties under the shelf reg­is­tra­tion state­ment.
A reg­is­tra­tion state­ment relat­ing to these secu­ri­ties has been filed with the Securities and Exchange Commission but has not yet become effec­tive. These secu­ri­ties may not be sold nor may offers to buy be accept­ed pri­or to the time the reg­is­tra­tion state­ment becomes effec­tive. This press release shall not con­sti­tute an offer to sell or the solic­i­ta­tion of an offer to buy these secu­ri­ties, nor shall there be any sale of these secu­ri­ties in any state or juris­dic­tion in which such offer, solic­i­ta­tion or sale would be unlaw­ful pri­or to reg­is­tra­tion or qual­i­fi­ca­tion under the secu­ri­ties laws of any such state or juris­dic­tion.
Any offer of these secu­ri­ties will be made sole­ly by means of the prospec­tus includ­ed in the reg­is­tra­tion state­ment and any prospec­tus sup­ple­ment that may be issued with respect to such offer­ing. When avail­able, copies of the prospec­tus and any accom­pa­ny­ing prospec­tus sup­ple­ment relat­ing to and describ­ing the terms of the offer­ing may be obtained from Prosensa Holding N.V., J.H. Oortweg 21, 2333 CH Leiden, The Netherlands, Attention: Celia Economides; c.economides@prosensa.nl.

Leave a Reply

Your email address will not be published. Required fields are marked *